DK3022174T3 - Derivater af n-urinstof-substituerede aminosyrer som formylpeptidreceptormodulatorer - Google Patents
Derivater af n-urinstof-substituerede aminosyrer som formylpeptidreceptormodulatorer Download PDFInfo
- Publication number
- DK3022174T3 DK3022174T3 DK14744725.4T DK14744725T DK3022174T3 DK 3022174 T3 DK3022174 T3 DK 3022174T3 DK 14744725 T DK14744725 T DK 14744725T DK 3022174 T3 DK3022174 T3 DK 3022174T3
- Authority
- DK
- Denmark
- Prior art keywords
- urine
- derivatives
- amino acids
- substituted amino
- receptor modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361846787P | 2013-07-16 | 2013-07-16 | |
PCT/US2014/046203 WO2015009545A1 (en) | 2013-07-16 | 2014-07-10 | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3022174T3 true DK3022174T3 (da) | 2019-01-02 |
Family
ID=51230227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14744725.4T DK3022174T3 (da) | 2013-07-16 | 2014-07-10 | Derivater af n-urinstof-substituerede aminosyrer som formylpeptidreceptormodulatorer |
Country Status (11)
Country | Link |
---|---|
US (1) | US9428549B2 (da) |
EP (1) | EP3022174B1 (da) |
JP (1) | JP6653253B2 (da) |
KR (1) | KR102313757B1 (da) |
CN (1) | CN105377814B (da) |
AU (1) | AU2014290618B2 (da) |
CA (1) | CA2917811C (da) |
DK (1) | DK3022174T3 (da) |
ES (1) | ES2708571T3 (da) |
RU (1) | RU2696581C2 (da) |
WO (1) | WO2015009545A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104114164B (zh) | 2011-10-26 | 2016-11-16 | 阿勒根公司 | 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物 |
KR20210024691A (ko) | 2013-03-06 | 2021-03-05 | 알러간, 인코포레이티드 | 피부 질환 치료용 포르밀 펩티드 수용체 2의 항진제의 용도 |
EP3071548B1 (en) | 2013-11-21 | 2017-11-08 | Allergan, Inc. | Phenylcarbamate derivatives as formyl peptide receptor modulators |
WO2015079692A1 (ja) | 2013-11-28 | 2015-06-04 | 杏林製薬株式会社 | ウレア誘導体、またはその薬理学的に許容される塩 |
US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
ES2788700T3 (es) | 2014-05-21 | 2020-10-22 | Allergan Inc | Derivados de imidazol como moduladores del receptor de péptido formilado |
CA2987235A1 (en) | 2015-05-27 | 2016-12-01 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
US10858314B2 (en) | 2015-05-27 | 2020-12-08 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
AU2016302146B2 (en) * | 2015-08-05 | 2021-01-28 | Allergan, Inc. | Phenyl urea analogs as formyl peptide receptor 1 (FPR1) selective agonists |
US10676431B2 (en) | 2018-03-05 | 2020-06-09 | Bristol-Myers Squibb Company | Phenylpyrrolidinone formyl peptide 2 receptor agonists |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2533210A1 (fr) | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | Edulcorants de synthese |
US5284828A (en) * | 1990-05-14 | 1994-02-08 | Fujisawa Pharmaceutical Co. Ltd. | Peptide compound and its preparation |
JP3387948B2 (ja) * | 1992-12-04 | 2003-03-17 | 富山化学工業株式会社 | 新規なフェニルアラニン誘導体またはその塩 |
US20030009022A1 (en) * | 1993-03-31 | 2003-01-09 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
JP2968842B2 (ja) * | 1994-02-09 | 1999-11-02 | 塩野義製薬株式会社 | カルバモイルメチルウレア誘導体 |
ES2171531T3 (es) * | 1994-02-09 | 2002-09-16 | Shionogi & Co | Derivados de carbamoilmetilurea. |
US6423689B1 (en) * | 1997-12-22 | 2002-07-23 | Warner-Lambert Company | Peptidyl calcium channel blockers |
AU4572999A (en) | 1998-06-18 | 2000-01-05 | Sepracor, Inc. | Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
WO2003082314A2 (en) * | 2002-04-03 | 2003-10-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
BRPI0416272A (pt) * | 2003-11-07 | 2007-01-09 | Acadia Pharm Inc | usos do receptor fprl1, e de compostos, uso profilático de compostos, métodos de triagem para um composto capaz de afetar uma ou mais atividades de um receptor fprl1, de tratamento ou prevenção de inflamação, de identificação de um composto de indução de vasodilatação, para antagonismo de uma resposta vasoconstrutiva a um sulfidopeptìdeo leucotrieno em um indivìduo, e para estimulação de proliferação celular em um indivìduo, e, composto |
KR101724765B1 (ko) * | 2009-05-18 | 2017-04-07 | 액테리온 파마슈티칼 리미티드 | Alx 수용체 및/또는 fprl2 아고니스트로서의 브릿지 스피로[2.4]헵탄 유도체 |
WO2012074785A1 (en) * | 2010-12-03 | 2012-06-07 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
CN104114164B (zh) * | 2011-10-26 | 2016-11-16 | 阿勒根公司 | 作为甲酰肽受体样-1(fprl-1)受体调节剂的n-脲取代的氨基酸的酰胺衍生物 |
US8541577B2 (en) * | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
US8735622B2 (en) * | 2011-11-30 | 2014-05-27 | The Regents Of The University Of Colorado, A Body Corporate | Histone demethylase inhibitors and methods for using the same |
KR20210024691A (ko) * | 2013-03-06 | 2021-03-05 | 알러간, 인코포레이티드 | 피부 질환 치료용 포르밀 펩티드 수용체 2의 항진제의 용도 |
CN110279684B (zh) * | 2013-03-06 | 2023-02-28 | 阿勒根公司 | 用于治疗眼部炎性疾病的甲酰基肽受体2激动剂的用途 |
-
2014
- 2014-07-10 CN CN201480040132.5A patent/CN105377814B/zh active Active
- 2014-07-10 WO PCT/US2014/046203 patent/WO2015009545A1/en active Application Filing
- 2014-07-10 US US14/328,540 patent/US9428549B2/en active Active
- 2014-07-10 RU RU2016104844A patent/RU2696581C2/ru active
- 2014-07-10 KR KR1020167003770A patent/KR102313757B1/ko active IP Right Grant
- 2014-07-10 DK DK14744725.4T patent/DK3022174T3/da active
- 2014-07-10 CA CA2917811A patent/CA2917811C/en active Active
- 2014-07-10 JP JP2016526992A patent/JP6653253B2/ja active Active
- 2014-07-10 EP EP14744725.4A patent/EP3022174B1/en active Active
- 2014-07-10 ES ES14744725T patent/ES2708571T3/es active Active
- 2014-07-10 AU AU2014290618A patent/AU2014290618B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2708571T3 (es) | 2019-04-10 |
EP3022174B1 (en) | 2018-09-05 |
KR102313757B1 (ko) | 2021-10-18 |
WO2015009545A1 (en) | 2015-01-22 |
CA2917811A1 (en) | 2015-01-22 |
EP3022174A1 (en) | 2016-05-25 |
JP2016529235A (ja) | 2016-09-23 |
RU2016104844A (ru) | 2017-08-21 |
RU2696581C2 (ru) | 2019-08-05 |
AU2014290618A1 (en) | 2016-02-18 |
AU2014290618B2 (en) | 2018-04-05 |
US9428549B2 (en) | 2016-08-30 |
CA2917811C (en) | 2021-08-31 |
US20150025021A1 (en) | 2015-01-22 |
CN105377814A (zh) | 2016-03-02 |
CN105377814B (zh) | 2018-04-03 |
JP6653253B2 (ja) | 2020-02-26 |
KR20160031007A (ko) | 2016-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
DK3022174T3 (da) | Derivater af n-urinstof-substituerede aminosyrer som formylpeptidreceptormodulatorer | |
DK3239134T3 (da) | Pyridonamider som modulatorer af natriumkanaler | |
DK3360881T3 (da) | 11-hydroxy-6-substituerede derivater af galdesyrer og aminosyrekonjagater deraf som farnesoid X receptormodulatorer | |
DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
DK3786162T3 (da) | Bipyrazolderivater som jak-inhibitorer | |
DK3083540T3 (da) | Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner | |
DK3848027T3 (da) | Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer | |
DK3322701T3 (da) | Ethynylderivater som metabotropiske glutamatreceptormodulatorer | |
DK3022217T3 (da) | Sammensætninger til modulering af tau-ekspression | |
DK2906696T4 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
DK2845905T3 (da) | Fremstilling af oligosaccharider | |
DK3087183T3 (da) | Modulation af angiopoietin-3-lignende ekspression | |
DK2840065T3 (da) | Fremgangsmåde til fremstilling af præcipiteret calciumcarbonat | |
DK3181364T3 (da) | Godkendelse af forsyning via timing-challenge-respons | |
DK2970954T3 (da) | Modifikation af polypeptider | |
DK2968529T3 (da) | Fremstilling af jordnøddeformuleringer til oral desensibilisering | |
DK3533792T3 (da) | Krystallinske former af en androgenreceptormodulator | |
DK3539961T3 (da) | Polycykliske amidderivativer som cdk9-inhibitorer | |
DK3590517T3 (da) | Heteroaryl-ketonkondenserede azadecalin som modulatorer af glucocorticoidreceptorer | |
DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
SMT201700009B (it) | Modulatori del recettore x del fegato | |
DK2999699T3 (da) | Purindioner som wnt-vej-modulatorer |